Brainstorm Cell Therapeutics (BCLI) Non-Current Assets (2010 - 2026)
Brainstorm Cell Therapeutics (BCLI) reported Non-Current Assets of $472,000 for Q2 2026, down 55.1% from $1.05 million a year earlier and down 17.3% from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Brainstorm Cell Therapeutics posted Non-Current Assets of $715,000, down 50.6% from FY2024.
- Non-Current Assets has declined for five consecutive years, with a five-year compound annual growth rate of -38.3% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $1.45 million in FY2024 (-37.3%), $2.31 million in FY2023 (-56.8%), $5.35 million in FY2022 (-10.9%) and $6 million in FY2021 (-25.2%).
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets since Q3 2017.
- Year over year, Non-Current Assets has now declined in each of the last 19 quarters, with an average decline of 48.6% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q3 2021 (growth of 180.1%); the low point was Q3 2024 (a decline of 59.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $571,000 (Q1 2026), $715,000 (Q4 2025) and $872,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.82 Bn | 1,135.41 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 644.52 Bn | 564.38 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 501.88 Bn | 474.99 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 358.72 Bn | 313.10 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 302.27 Bn | 266.26 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 267.62 Bn | 241.31 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 241.67 Bn | 197.07 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.60 Bn | 118.24 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Brainstorm Cell Therapeutics | 8.50 Mn | 8.43 Mn | - | 472,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 472,000.00 |
| Mar 31, 2026 | 571,000.00 |
| Dec 31, 2025 | 715,000.00 |
| Sep 30, 2025 | 872,000.00 |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.87 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 4.14 Mn |
| Jun 30, 2023 | 4.53 Mn |
| Mar 31, 2023 | 4.94 Mn |
| Dec 31, 2022 | 5.35 Mn |
| Sep 30, 2022 | 5.75 Mn |
| Jun 30, 2022 | 6.16 Mn |
| Mar 31, 2022 | 6.53 Mn |
| Dec 31, 2021 | 6.00 Mn |
| Sep 30, 2021 | 6.59 Mn |
API Access
Brainstorm Cell Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();